These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34712948)

  • 21. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
    Tauqeer F; Myhr K; Gopinathan U
    Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
    Salcher-Konrad M; Naci H; Davis C
    Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data Integrity: History, Issues, and Remediation of Issues.
    Rattan AK
    PDA J Pharm Sci Technol; 2018; 72(2):105-116. PubMed ID: 29158286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships among Healthcare Digitalization, Social Capital, and Supply Chain Performance in the Healthcare Manufacturing Industry.
    Kim HK; Lee CW
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future.
    Arden NS; Fisher AC; Tyner K; Yu LX; Lee SL; Kopcha M
    Int J Pharm; 2021 Jun; 602():120554. PubMed ID: 33794326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.
    Boesen K; Gøtzsche PC; Ioannidis JPA
    Epidemiol Psychiatr Sci; 2021 Apr; 30():e35. PubMed ID: 33926608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal.
    Brhlikova P; Harper I; Subedi M; Bhattarai S; Rawal N; Pollock AM
    Global Health; 2015 Jun; 11():25. PubMed ID: 26072308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Good Clinical Practice Inspection Processes for Marketing Applications Between the United States Food and Drug Administration and the European Medicines Agency.
    Ayalew K; Ning YM; Foringer MJ; Leibenhaut S; Sellers JW; Yu B; Kronstein PD; Higgerson A; Mihaescu C; Rodriguez M; Williams L; Khin NA
    Ther Innov Regul Sci; 2023 Jan; 57(1):79-85. PubMed ID: 35972722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections.
    Geyer ARC; Sousa VD; Silveira D
    PLoS One; 2018; 13(8):e0202084. PubMed ID: 30089162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Physicians in Digitalizing Health Care Provision: Web-Based Survey Study.
    Burmann A; Tischler M; Faßbach M; Schneitler S; Meister S
    JMIR Med Inform; 2021 Nov; 9(11):e31527. PubMed ID: 34545813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paediatric Medicines - Regulatory Drivers, Restraints, Opportunities and Challenges.
    Vieira I; Sousa JJ; Vitorino C
    J Pharm Sci; 2021 Apr; 110(4):1545-1556. PubMed ID: 33421435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unleashing the Potential of Digitalization in the Agri-Food Chain for Integrated Food Systems.
    Krupitzer C; Stein A
    Annu Rev Food Sci Technol; 2024 Jun; 15(1):307-328. PubMed ID: 37931153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of condition-based maintenance framework for process operations management in pharmaceutical continuous manufacturing.
    Ganesh S; Su Q; Vo LBD; Pepka N; Rentz B; Vann L; Yazdanpanah N; O'Connor T; Nagy ZK; Reklaitis GV
    Int J Pharm; 2020 Sep; 587():119621. PubMed ID: 32663581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digitalization, Electricity Consumption and Carbon Emissions-Evidence from Manufacturing Industries in China.
    Zhang Q; Wang Q
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Strategies for digitalizing the hospital of the future].
    Deiters W; Burmann A; Meister S
    Urologe A; 2018 Sep; 57(9):1031-1039. PubMed ID: 30088025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices.
    Petrelli F; Caraffa A; Scuri S; Grappasonni I; Magrini E; Cocchini A
    Acta Biomed; 2019 May; 90(2):288-299. PubMed ID: 31125009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration.
    Yousefi N; Moradi N; Dinarvand R; Ghiasi G; Inanloo H; Peiravian F
    Daru; 2019 Jun; 27(1):169-177. PubMed ID: 30903556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of the European regulatory approval system.
    Pignatti F; Boone H; Moulon I
    J Ambul Care Manage; 2004; 27(2):89-97. PubMed ID: 15069985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.